High Prevalence and Diversity of Kidney Dysfunction in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The BARI 2D Baseline Data

被引:16
作者
Wall, Barry M. [1 ,2 ]
Hardison, Regina M. [3 ]
Molitch, Mark E. [7 ]
Marroquin, Oscar C. [4 ,5 ,6 ,8 ]
McGill, Janet B. [9 ]
August, Phyllis A. [10 ]
机构
[1] Vet Affairs Med Ctr, Memphis, TN 38104 USA
[2] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA
[3] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA
[4] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA
[5] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA
[6] Univ Pittsburgh, Div Cardiol, Pittsburgh, PA USA
[7] Northwestern Univ, Med Ctr, Div Endocrinol Metab & Mol Med, Feinberg Sch Med, Chicago, IL 60611 USA
[8] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[9] Washington Univ, Dept Med, Div Endocrinol Metab & Lipid Res, Barnes Jewish Hosp, St Louis, MO USA
[10] Weill Cornell Med Coll, Div Nephrol & Hypertens, New York, NY USA
关键词
Diabetes mellitus; Albuminuria; Chronic kidney disease; Clinical epidemiology; Clinical trial; GLOMERULAR-FILTRATION-RATE; ALL-CAUSE MORTALITY; RENAL-INSUFFICIENCY; CARDIOVASCULAR EVENTS; MULTIFACTORIAL INTERVENTION; MICROALBUMINURIA; ALBUMINURIA; RISK; DEATH; INDIVIDUALS;
D O I
10.1097/MAJ.0b013e3181d430ad
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: We describe baseline renal function and albumin excretion rate in patients enrolled in Bypass Angioplasty Revascularization Investigation 2 Diabetes, a randomized clinical trial comparing the impact of revascularization and medical therapy with medical therapy alone and deferred or no revascularization and the impact of glycemic control with either insulin-providing or insulin-sensitizing drugs, on 5-year mortality. Methods: Study participants had type 2 diabetes mellitus, documented coronary artery disease, and creatinine <2 mg/dL. Albuminuria status (albumin/creatinine ratio [ACR]) and estimated glomerular filtration rate (eGFR), using the abbreviated Modified Diet in Renal Disease equation, were determined at baseline. Univariate and multivariate relationships between baseline clinical characteristics and the presence of albuminuria and reduced eGFR rate were estimated. Results: Two thousand one hundred forty-six subjects were included in the analysis. Forty-three percent of the cohort had evidence of kidney dysfunction at baseline: 23% had an eGFR >= 60 mL/min/1.73 m(2) with either microalbuminuria (>30 ACR; 17%) or macroalbuminuria (>300 ACR; 6%). Twenty-one percent had a reduced eGFR >= 60 mL/min/1.73 m(2); 52% with reduced eGFR had no albuminuria; 28% had microalbuminuria, and 20% had macroalbuminuria. Race, smoking status, duration of diabetes, hypertension, hemoglobin A1c, triglycerides, vascular disease, abnormal ejection fraction, and reduced eGFR were associated with greater albuminuria. Age, sex, duration of diabetes, ACR, hemoglobin A1c, high density lipoprotein, and number of hypertensive medications were associated with reduced eGFR. Conclusion: Kidney dysfunction is common in older patients with type 2 diabetes mellitus and coronary artery disease; Albuminuria was present in 33%. Reduced eGFR was present in 21%, and half the patients with reduced eGFR had no evidence of albuminuria.
引用
收藏
页码:401 / 410
页数:10
相关论文
共 50 条
  • [41] Diabetes mellitus Type 2: Coronary calcifications as a predictor of coronary artery disease
    Becker, A
    Knez, A
    Leber, A
    Boekstegers, P
    Steinbeck, G
    HERZ, 2004, 29 (05) : 488 - 495
  • [42] Diabetes mellitus type 2: Coronary calcifications as a predictor of coronary artery disease
    Becker A.
    Knez A.
    Leber A.
    Boekstegers P.
    Steinbeck G.
    Herz, 2004, 29 (5) : 488 - 495
  • [43] Plasma adiponectin is related to the progression of kidney disease in type 2 diabetes patients
    Kacso, Ina Maria
    Bondor, Cosmina Ioana
    Kacso, Gabriel
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2012, 72 (04) : 333 - 339
  • [44] Comprehensive risk management of diabetic kidney disease in patients with type 2 diabetes mellitus
    Araki S.-I.
    Diabetology International, 2018, 9 (2) : 100 - 107
  • [45] Impact of chronic kidney disease on the prevalence of cardiovascular disease in patients with type 2 diabetes in Spain: PERCEDIME2 study
    Rodriguez-Poncelas, Antonio
    Coll-De Tuero, Gabriel
    Turro-Garriga, Oriol
    Barrot-de la Puente, Joan
    Franch-Nadal, Josep
    Mundet-Tuduri, Xavier
    BMC NEPHROLOGY, 2014, 15
  • [46] Frequency of Hypogonadism in Type 2 Diabetes Mellitus Patients with and without Coronary Artery Disease
    Raza, Muhammad T.
    Sharif, Sabira
    Khan, Zohaib Ahmad
    Naz, Sadaf
    Mushtaq, Samsam
    Umer, Amina
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (12)
  • [47] Metabolomic Signature of Coronary Artery Disease in Type 2 Diabetes Mellitus
    Stratmann, Bernd
    Richter, Katrin
    Wang, Ruichao
    Yu, Zhonghao
    Xu, Tao
    Prehn, Cornelia
    Adamski, Jerzy
    Illig, Thomas
    Tschoepe, Diethelm
    Wang-Sattler, Rui
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2017, 2017
  • [48] Serum cystatin C levels are associated with asymptomatic peripheral arterial disease in type 2 diabetes mellitus patients without overt nephropathy
    Huh, Ji Hye
    Choi, EunHee
    Lim, Jung Soo
    Lee, Mi Young
    Chung, Choon Hee
    Shin, Jang Yel
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 108 (02) : 258 - 264
  • [49] Influence of chronic kidney disease on coronary plaque components in coronary artery disease patients with both diabetes mellitus and hypertension
    Shigemoto, Eiji
    Iwata, Atsushi
    Futami, Makito
    Kato, Yuta
    Yamashita, Motoki
    Imaizumi, Satoshi
    Kuwano, Takashi
    Ike, Amane
    Sugihara, Makoto
    Saku, Keijiro
    Miura, Shin-ichiro
    HEART AND VESSELS, 2019, 34 (07) : 1065 - 1075
  • [50] Effect of metformin on kidney function in patients with type 2 diabetes mellitus and moderate chronic kidney disease
    Hsu, Wei-Hao
    Hsiao, Pi-Jung
    Lin, Pi-Chen
    Chen, Szu-Chia
    Lee, Mei-Yueh
    Shin, Shyi-Jang
    ONCOTARGET, 2018, 9 (04) : 5416 - 5423